RHS logo

RHS - RHS Share Price

A$0.275 0.0  0.0%

Last Trade - 29/05/18

Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £116k
Position in Universe th / 1911
Unlock RHS Revenue
Relative Strength (%)
1m +2.43%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2012 2013 2014 2015 2016 2017 2018E 2019E CAGR / Avg
0.008 0.30 0.25 0.073 0.076 0.21 +93.9%
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2017, RHS Ltdrevenues increased from A$76K to A$211K. Net loss increased10% to A$2M. Revenues reflect an increase in demand for theCompany's products and services due to favorable marketconditions. Higher net loss reflects Employee benefitsexpense increase of 23% to A$1.2M (expense), Consultantsand professional fees increase of 54% to A$289K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


RHS Revenue Unlock RHS Revenue

Net Income

RHS Net Income Unlock RHS Revenue

Normalised EPS

RHS Normalised EPS Unlock RHS Revenue

PE Ratio Range

RHS PE Ratio Range Unlock RHS Revenue

Dividend Yield Range

RHS Dividend Yield Range Unlock RHS Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
RHS EPS Forecasts Unlock RHS Revenue
Profile Summary

RHS Limited, formerly Reproductive Health Science Limited, is engaged in the product development and commercialization of biotechnology technologies. Its principal activities include the development and marketing of its biotechnology technologies, including its products, EmbryoCellect for Preimplantation Genetic Screening (PGS) and DOPlify Whole Genome Amplification kit (WGA). EmbryoCellect uses microarray technology (array Comparative Genomic Hybridization) to compare the number of chromosomes in a sample cell to a known reference sample. The samples are labelled with various fluorescent dyes and the amount of fluorescence is measured and compared for each chromosome. It helps in counting the number of chromosomes in the test cell. DOPlify captures know-how for the lysis and whole genome amplification of single or small numbers of cells providing a solution for multiplying the limited deoxyribonucleic acid in a single cell for a range of downstream applications.

Last Annual December 31st, 2017
Last Interim December 31st, 2017
Incorporated March 21, 1980
Public Since March 5, 1987
No. of Shareholders: n/a
No. of Employees: 3
Sector Healthcare
Industry Biotechnology & Medical Research
Exchange Australian Stock Exchange - SEATS
Shares in Issue 111,710,965
Free Float (0.0%)
Eligible for
RHS Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for RHS
Upcoming Events for RHS
Frequently Asked Questions for RHS
What is the RHS share price?

As of 29/05/18, shares in RHS are trading at A$0.275, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the RHS share price performed this year?

Shares in RHS are currently trading at A$0.275 and the price has moved by 77.42% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the RHS price has moved by 32.78% over the past year.

What are the analyst and broker recommendations for RHS?

There are no analysts currently covering RHS.

When will RHS next release its financial results?

RHS is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2018-12-31
What is the RHS dividend yield?

RHS does not currently pay a dividend.

Does RHS pay a dividend?

RHS does not currently pay a dividend.

When does RHS next pay dividends?

RHS does not currently pay a dividend.

How do I buy RHS shares?

To buy shares in RHS you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of RHS?

Shares in RHS are currently trading at A$0.275, giving the company a market capitalisation of £n/a.

Where are RHS shares listed? Where are RHS shares listed?

Here are the trading details for RHS:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: RHS
What kind of share is RHS?

We were not able to load our ranking data for RHS

Is there a RHS share price forecast 2021?

We were not able to load any forecast data for RHS.

How can I tell whether the RHS share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like RHS. Over the past six months, the relative strength of its shares against the market has been 81.44%. At the current price of A$0.275, shares in RHS are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the RHS PE Ratio?

We were not able to find PE ratio data for RHS.

Who are the key directors of RHS?

We were unable to find the directors for RHS.

Who are the major shareholders of RHS?

Here are the top five shareholders of RHS based on the size of their shareholding:

Similar to RHS
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.